BC Partners in talks to acquire natural healthcare business Havea

Charles Wheeldon
June 23, 2022
M&A

Funds advised by international investment firm BC Partners today announced it has entered into exclusive discussions to acquire a majority stake in Havea, the French natural healthcare company, from 3i Group. Terms of the transaction were not disclosed.

BC Partners is negotiating the deal in partnership with PSP Investments and National Pensions Services Investment Management.

Headquartered in Boufféré, France, Havea has a presence across Europe and employs more 800 people.

BC Partners stated it would support Havea’s management team to execute its organic growth strategy and help accelerate its pace of M&A with complementary businesses and continue investing in digitalisation.

Mark Hersee, partner at BC Partners, said: “Havea benefits from long-term structural tailwinds, and embodies the key themes that we look for in a healthcare business, particularly in pharma, of providing strong value to patients and healthcare payors alike, preventative care, and digitalisation. Havea has an outstanding track record of delivery, true market leadership, and a best-in-class management team, which are key criteria we seek in our investments. We look forward to working with the management team in realising the full potential of the group.”

Fouad Jaïdi, managing director at BC Partners, added: “Consistent with our owner-operator mindset we are excited to help Nicolas Brodetsky, CEO of Havea, and his team execute on their strategy and support them in pursuing value accretive transactions. The business has made five key strategic acquisitions since 2017, and we look forward to working with the team to drive Havea’s continued international expansion. We will use our expertise to support the company’s continued focus on meeting customer needs via increased investment in digitalisation.”

Brodetsky commented: “We welcome this opportunity to partner with BC Partners, which has extensive experience in fostering portfolio companies’ potential and will support us in this next and exciting stage of our growth, with a continued focus on improving our consumers quality of life with natural products. We share a common vision of the winning strategy to accelerate our development on a larger scale and become the undisputed European leader. We thank 3i for their active support, which has helped Havea grow and establish its leadership position in natural healthcare.”

David Morin, managing director and head of Europe, private equity at PSP Investments, said: “Over the last years, Nicolas Brodetsky, CEO of Havea, and his talented team have built great brands and have positioned Havea to benefit from industry tailwinds. We are excited to team up with BC Partners, who have been one of PSP Investments’ core partners for many years. Together, we will provide the long-term strategic capital to support Havea in achieving its full potential through its next phase of development as a European leader in natural healthcare.”

Subscriber content

To get unlimited access subscribe today

Subscribe

Already a subscriber? Login